|
|
Hokkaido University Collection of Scholarly and Academic Papers >
Hokkaido University Hospital >
Peer-reviewed Journal Articles, etc >
Investigation of the risk factors of vomiting during linezolid therapy : a retrospective observational study
| Title: | Investigation of the risk factors of vomiting during linezolid therapy : a retrospective observational study |
| Authors: | Tsutsumi, Takezo Browse this author | | Imai, Shungo Browse this author →KAKEN DB | | Kashiwagi, Hitoshi Browse this author | | Sato, Yuki Browse this author | | Sugawara, Mitsuru Browse this author | | Takekuma, Yoh Browse this author →KAKEN DB |
| Keywords: | Linezolid | | Nausea and vomiting | | Adverse drug effects | | Hyponatraemia |
| Issue Date: | 1-Feb-2022 |
| Publisher: | Springer |
| Journal Title: | European Journal of Clinical Pharmacology |
| Volume: | 78 |
| Issue: | 2 |
| Start Page: | 279 |
| End Page: | 286 |
| Publisher DOI: | 10.1007/s00228-021-03221-x |
| Abstract: | Purpose Some clinical studies have reported the occurrence of nausea and vomiting with linezolid (LZD) administration. However, no studies have evaluated nausea and vomiting as primary endpoints. In a previous study, we noted a possible relationship between LZD and vomiting, but risk factors were not identified. Therefore, the aim of the present study was to identify them. Methods Patients who received LZD 600 mg twice daily at Hokkaido University Hospital from September 2008 to April 2019 were enrolled in this retrospective observational study. Patient characteristics, concomitant medications, laboratory data, and the occurrence of vomiting were obtained from electronic medical records. Logistic regression analysis was performed to identify risk factors for vomiting, including age, sex, body weight, concomitant medications, and surgeries. Results A total of 496 patients were included in this study, of which 90 experienced vomiting. By multivariate logistic regression analysis, female sex (adjusted odds ratio [aOR], 2.69; 95% confidence interval [CI], 1.62-4.47), >= 10 days of LZD administration (aOR, 2.57; CI, 1.46-4.50), and hyponatraemia (aOR, 2.96; CI, 1.72-5.10) were identified as independent risk factors for vomiting; administration of serotonergic agents (aOR, 0.23; CI, 0.07-0.82) was negatively associated. Conclusions This study is the first to successfully identify risk factors for LZD-induced vomiting. Careful monitoring of patients with these risk factors may lead to safer and sustainable LZD administration. |
| Rights: | The final publication is available at Springer via http://dx.doi.org/10.1007/s00228-021-03221-x |
| Type: | article (author version) |
| URI: | http://hdl.handle.net/2115/84482 |
| Appears in Collections: | 北海道大学病院 (Hokkaido University Hospital) > 雑誌発表論文等 (Peer-reviewed Journal Articles, etc)
|
Submitter: 武隈 洋
|
